ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antiserum Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-10V3651
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Antiserum Market Insights Forecast to 2028
BUY CHAPTERS

Global Antiserum Market Research Report 2025

Code: QYRE-Auto-10V3651
Report
March 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
SSI Diagnostica
BD
GD Animal Health
Bio Rad
China National Pharmaceutical Group
CSL Limited
Merck
BTG Plc
Pfizer Inc
Haffkine Bio Pharmaceutical
Vins Bioproducts
Bharat Serums and Vaccines
MicroPharm
Rare Disease Therapeutics
Shanghai Serum Bio-Technology Co., Ltd.
Peptide Institute Inc.

Antiserum Market Size

The global market for Antiserum was valued at US$ 1495 million in the year 2024 and is projected to reach a revised size of US$ 2360 million by 2031, growing at a CAGR of 6.8% during the forecast period.

Antiserum Market

Antiserum Market

Antiserum, is a type of blood serum that contains specific antibodies against an antigen (foreign agent), such as an infective organism or poisonous substance. Antibodies in antiserum work by detecting and subsequently neutralizing antigens.
Antiserums are produced in animals, most commonly horses, sheep, oxen, and rabbits, and in humans, in response to infection, intoxication, or vaccination. Animal and human antiserums can be used in other individuals to confer immunity to a specific disease or to treat bites or stings of venomous animals.
Antiserum widely used in diagnostic virology laboratories. The most common use of antiserum in humans is as antitoxin or antivenom to treat envenomation.
Global 5 largest manufacturers of Antiserum are CSL, Merck, BTG, Pfizer and CNBG, which make up over 58%. Among them, CSL is the leader with about 16% market share.
Asia-Pacific is the largest market, with a share about 47%, followed by North America and Middle East and Africa, with the share about 24% and 12%. In terms of product type, Antitoxin Serum occupies the largest share of the total market, about 61%. And in terms of application, the largest application is Clinical, followed by Laboratory.
This report aims to provide a comprehensive presentation of the global market for Antiserum, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiserum.
The Antiserum market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antiserum market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiserum companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Antiserum Market Report

Report Metric Details
Report Name Antiserum Market
Accounted market size in year US$ 1495 million
Forecasted market size in 2031 US$ 2360 million
CAGR 6.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Clinical
  • Laboratory
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BD, Bio-Rad, Shanghai Serum Bio-Technology Co., Ltd., China National Pharmaceutical Group, CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Vins Bioproducts, Bharat Serums and Vaccines, SSI Diagnostica, GD Animal Health, MicroPharm, Peptide Institute Inc., Rare Disease Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Antiserum company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Antiserum Market growing?

Ans: The Antiserum Market witnessing a CAGR of 6.8% during the forecast period 2025-2031.

What is the Antiserum Market size in 2031?

Ans: The Antiserum Market size in 2031 will be US$ 2360 million.

What is the CSL, Merck, BTG, Pfizer share in Antiserum Market?

Ans: Global 5 largest manufacturers of Antiserum are CSL, Merck, BTG, Pfizer and CNBG, which make up over 58%.

What is the CSL share in Antiserum Market?

Ans: Among them, CSL is the leader with about 16% market share.

What is the Antiserum Market share by type?

Ans: In terms of product type, Antitoxin Serum occupies the largest share of the total market, about 61%.

Who are the main players in the Antiserum Market report?

Ans: The main players in the Antiserum Market are BD, Bio-Rad, Shanghai Serum Bio-Technology Co., Ltd., China National Pharmaceutical Group, CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Vins Bioproducts, Bharat Serums and Vaccines, SSI Diagnostica, GD Animal Health, MicroPharm, Peptide Institute Inc., Rare Disease Therapeutics

What are the Application segmentation covered in the Antiserum Market report?

Ans: The Applications covered in the Antiserum Market report are Clinical, Laboratory

What are the Type segmentation covered in the Antiserum Market report?

Ans: The Types covered in the Antiserum Market report are Antitoxin Serum, Antibacterial Serum, Antiviral Serum, Others

Recommended Reports

Antibody and Serum Markets

Diagnostic and Testing

Antibody Services & Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiserum Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antitoxin Serum
1.2.3 Antibacterial Serum
1.2.4 Antiviral Serum
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antiserum Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical
1.3.3 Laboratory
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiserum Market Perspective (2020-2031)
2.2 Global Antiserum Growth Trends by Region
2.2.1 Global Antiserum Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antiserum Historic Market Size by Region (2020-2025)
2.2.3 Antiserum Forecasted Market Size by Region (2026-2031)
2.3 Antiserum Market Dynamics
2.3.1 Antiserum Industry Trends
2.3.2 Antiserum Market Drivers
2.3.3 Antiserum Market Challenges
2.3.4 Antiserum Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiserum Players by Revenue
3.1.1 Global Top Antiserum Players by Revenue (2020-2025)
3.1.2 Global Antiserum Revenue Market Share by Players (2020-2025)
3.2 Global Antiserum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antiserum Revenue
3.4 Global Antiserum Market Concentration Ratio
3.4.1 Global Antiserum Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiserum Revenue in 2024
3.5 Global Key Players of Antiserum Head office and Area Served
3.6 Global Key Players of Antiserum, Product and Application
3.7 Global Key Players of Antiserum, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiserum Breakdown Data by Type
4.1 Global Antiserum Historic Market Size by Type (2020-2025)
4.2 Global Antiserum Forecasted Market Size by Type (2026-2031)
5 Antiserum Breakdown Data by Application
5.1 Global Antiserum Historic Market Size by Application (2020-2025)
5.2 Global Antiserum Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antiserum Market Size (2020-2031)
6.2 North America Antiserum Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antiserum Market Size by Country (2020-2025)
6.4 North America Antiserum Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiserum Market Size (2020-2031)
7.2 Europe Antiserum Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antiserum Market Size by Country (2020-2025)
7.4 Europe Antiserum Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiserum Market Size (2020-2031)
8.2 Asia-Pacific Antiserum Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antiserum Market Size by Region (2020-2025)
8.4 Asia-Pacific Antiserum Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antiserum Market Size (2020-2031)
9.2 Latin America Antiserum Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antiserum Market Size by Country (2020-2025)
9.4 Latin America Antiserum Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiserum Market Size (2020-2031)
10.2 Middle East & Africa Antiserum Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antiserum Market Size by Country (2020-2025)
10.4 Middle East & Africa Antiserum Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Antiserum Introduction
11.1.4 BD Revenue in Antiserum Business (2020-2025)
11.1.5 BD Recent Development
11.2 Bio-Rad
11.2.1 Bio-Rad Company Details
11.2.2 Bio-Rad Business Overview
11.2.3 Bio-Rad Antiserum Introduction
11.2.4 Bio-Rad Revenue in Antiserum Business (2020-2025)
11.2.5 Bio-Rad Recent Development
11.3 Shanghai Serum Bio-Technology Co., Ltd.
11.3.1 Shanghai Serum Bio-Technology Co., Ltd. Company Details
11.3.2 Shanghai Serum Bio-Technology Co., Ltd. Business Overview
11.3.3 Shanghai Serum Bio-Technology Co., Ltd. Antiserum Introduction
11.3.4 Shanghai Serum Bio-Technology Co., Ltd. Revenue in Antiserum Business (2020-2025)
11.3.5 Shanghai Serum Bio-Technology Co., Ltd. Recent Development
11.4 China National Pharmaceutical Group
11.4.1 China National Pharmaceutical Group Company Details
11.4.2 China National Pharmaceutical Group Business Overview
11.4.3 China National Pharmaceutical Group Antiserum Introduction
11.4.4 China National Pharmaceutical Group Revenue in Antiserum Business (2020-2025)
11.4.5 China National Pharmaceutical Group Recent Development
11.5 CSL
11.5.1 CSL Company Details
11.5.2 CSL Business Overview
11.5.3 CSL Antiserum Introduction
11.5.4 CSL Revenue in Antiserum Business (2020-2025)
11.5.5 CSL Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Antiserum Introduction
11.6.4 Merck Revenue in Antiserum Business (2020-2025)
11.6.5 Merck Recent Development
11.7 BTG
11.7.1 BTG Company Details
11.7.2 BTG Business Overview
11.7.3 BTG Antiserum Introduction
11.7.4 BTG Revenue in Antiserum Business (2020-2025)
11.7.5 BTG Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Antiserum Introduction
11.8.4 Pfizer Revenue in Antiserum Business (2020-2025)
11.8.5 Pfizer Recent Development
11.9 Haffkine Bio-Pharmaceutical
11.9.1 Haffkine Bio-Pharmaceutical Company Details
11.9.2 Haffkine Bio-Pharmaceutical Business Overview
11.9.3 Haffkine Bio-Pharmaceutical Antiserum Introduction
11.9.4 Haffkine Bio-Pharmaceutical Revenue in Antiserum Business (2020-2025)
11.9.5 Haffkine Bio-Pharmaceutical Recent Development
11.10 Vins Bioproducts
11.10.1 Vins Bioproducts Company Details
11.10.2 Vins Bioproducts Business Overview
11.10.3 Vins Bioproducts Antiserum Introduction
11.10.4 Vins Bioproducts Revenue in Antiserum Business (2020-2025)
11.10.5 Vins Bioproducts Recent Development
11.11 Bharat Serums and Vaccines
11.11.1 Bharat Serums and Vaccines Company Details
11.11.2 Bharat Serums and Vaccines Business Overview
11.11.3 Bharat Serums and Vaccines Antiserum Introduction
11.11.4 Bharat Serums and Vaccines Revenue in Antiserum Business (2020-2025)
11.11.5 Bharat Serums and Vaccines Recent Development
11.12 SSI Diagnostica
11.12.1 SSI Diagnostica Company Details
11.12.2 SSI Diagnostica Business Overview
11.12.3 SSI Diagnostica Antiserum Introduction
11.12.4 SSI Diagnostica Revenue in Antiserum Business (2020-2025)
11.12.5 SSI Diagnostica Recent Development
11.13 GD Animal Health
11.13.1 GD Animal Health Company Details
11.13.2 GD Animal Health Business Overview
11.13.3 GD Animal Health Antiserum Introduction
11.13.4 GD Animal Health Revenue in Antiserum Business (2020-2025)
11.13.5 GD Animal Health Recent Development
11.14 MicroPharm
11.14.1 MicroPharm Company Details
11.14.2 MicroPharm Business Overview
11.14.3 MicroPharm Antiserum Introduction
11.14.4 MicroPharm Revenue in Antiserum Business (2020-2025)
11.14.5 MicroPharm Recent Development
11.15 Peptide Institute Inc.
11.15.1 Peptide Institute Inc. Company Details
11.15.2 Peptide Institute Inc. Business Overview
11.15.3 Peptide Institute Inc. Antiserum Introduction
11.15.4 Peptide Institute Inc. Revenue in Antiserum Business (2020-2025)
11.15.5 Peptide Institute Inc. Recent Development
11.16 Rare Disease Therapeutics
11.16.1 Rare Disease Therapeutics Company Details
11.16.2 Rare Disease Therapeutics Business Overview
11.16.3 Rare Disease Therapeutics Antiserum Introduction
11.16.4 Rare Disease Therapeutics Revenue in Antiserum Business (2020-2025)
11.16.5 Rare Disease Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
SSI Diagnostica
BD
GD Animal Health
Bio Rad
China National Pharmaceutical Group
CSL Limited
Merck
BTG Plc
Pfizer Inc
Haffkine Bio Pharmaceutical
Vins Bioproducts
Bharat Serums and Vaccines
MicroPharm
Rare Disease Therapeutics
Shanghai Serum Bio-Technology Co., Ltd.
Peptide Institute Inc.
List of Tables
 Table 1. Global Antiserum Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Antitoxin Serum
 Table 3. Key Players of Antibacterial Serum
 Table 4. Key Players of Antiviral Serum
 Table 5. Key Players of Others
 Table 6. Global Antiserum Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Antiserum Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Antiserum Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Antiserum Market Share by Region (2020-2025)
 Table 10. Global Antiserum Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Antiserum Market Share by Region (2026-2031)
 Table 12. Antiserum Market Trends
 Table 13. Antiserum Market Drivers
 Table 14. Antiserum Market Challenges
 Table 15. Antiserum Market Restraints
 Table 16. Global Antiserum Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Antiserum Market Share by Players (2020-2025)
 Table 18. Global Top Antiserum Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiserum as of 2024)
 Table 19. Ranking of Global Top Antiserum Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Antiserum Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Antiserum, Headquarters and Area Served
 Table 22. Global Key Players of Antiserum, Product and Application
 Table 23. Global Key Players of Antiserum, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Antiserum Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Antiserum Revenue Market Share by Type (2020-2025)
 Table 27. Global Antiserum Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Antiserum Revenue Market Share by Type (2026-2031)
 Table 29. Global Antiserum Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Antiserum Revenue Market Share by Application (2020-2025)
 Table 31. Global Antiserum Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Antiserum Revenue Market Share by Application (2026-2031)
 Table 33. North America Antiserum Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Antiserum Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Antiserum Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Antiserum Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Antiserum Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Antiserum Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Antiserum Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Antiserum Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Antiserum Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Antiserum Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Antiserum Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Antiserum Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Antiserum Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Antiserum Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Antiserum Market Size by Country (2026-2031) & (US$ Million)
 Table 48. BD Company Details
 Table 49. BD Business Overview
 Table 50. BD Antiserum Product
 Table 51. BD Revenue in Antiserum Business (2020-2025) & (US$ Million)
 Table 52. BD Recent Development
 Table 53. Bio-Rad Company Details
 Table 54. Bio-Rad Business Overview
 Table 55. Bio-Rad Antiserum Product
 Table 56. Bio-Rad Revenue in Antiserum Business (2020-2025) & (US$ Million)
 Table 57. Bio-Rad Recent Development
 Table 58. Shanghai Serum Bio-Technology Co., Ltd. Company Details
 Table 59. Shanghai Serum Bio-Technology Co., Ltd. Business Overview
 Table 60. Shanghai Serum Bio-Technology Co., Ltd. Antiserum Product
 Table 61. Shanghai Serum Bio-Technology Co., Ltd. Revenue in Antiserum Business (2020-2025) & (US$ Million)
 Table 62. Shanghai Serum Bio-Technology Co., Ltd. Recent Development
 Table 63. China National Pharmaceutical Group Company Details
 Table 64. China National Pharmaceutical Group Business Overview
 Table 65. China National Pharmaceutical Group Antiserum Product
 Table 66. China National Pharmaceutical Group Revenue in Antiserum Business (2020-2025) & (US$ Million)
 Table 67. China National Pharmaceutical Group Recent Development
 Table 68. CSL Company Details
 Table 69. CSL Business Overview
 Table 70. CSL Antiserum Product
 Table 71. CSL Revenue in Antiserum Business (2020-2025) & (US$ Million)
 Table 72. CSL Recent Development
 Table 73. Merck Company Details
 Table 74. Merck Business Overview
 Table 75. Merck Antiserum Product
 Table 76. Merck Revenue in Antiserum Business (2020-2025) & (US$ Million)
 Table 77. Merck Recent Development
 Table 78. BTG Company Details
 Table 79. BTG Business Overview
 Table 80. BTG Antiserum Product
 Table 81. BTG Revenue in Antiserum Business (2020-2025) & (US$ Million)
 Table 82. BTG Recent Development
 Table 83. Pfizer Company Details
 Table 84. Pfizer Business Overview
 Table 85. Pfizer Antiserum Product
 Table 86. Pfizer Revenue in Antiserum Business (2020-2025) & (US$ Million)
 Table 87. Pfizer Recent Development
 Table 88. Haffkine Bio-Pharmaceutical Company Details
 Table 89. Haffkine Bio-Pharmaceutical Business Overview
 Table 90. Haffkine Bio-Pharmaceutical Antiserum Product
 Table 91. Haffkine Bio-Pharmaceutical Revenue in Antiserum Business (2020-2025) & (US$ Million)
 Table 92. Haffkine Bio-Pharmaceutical Recent Development
 Table 93. Vins Bioproducts Company Details
 Table 94. Vins Bioproducts Business Overview
 Table 95. Vins Bioproducts Antiserum Product
 Table 96. Vins Bioproducts Revenue in Antiserum Business (2020-2025) & (US$ Million)
 Table 97. Vins Bioproducts Recent Development
 Table 98. Bharat Serums and Vaccines Company Details
 Table 99. Bharat Serums and Vaccines Business Overview
 Table 100. Bharat Serums and Vaccines Antiserum Product
 Table 101. Bharat Serums and Vaccines Revenue in Antiserum Business (2020-2025) & (US$ Million)
 Table 102. Bharat Serums and Vaccines Recent Development
 Table 103. SSI Diagnostica Company Details
 Table 104. SSI Diagnostica Business Overview
 Table 105. SSI Diagnostica Antiserum Product
 Table 106. SSI Diagnostica Revenue in Antiserum Business (2020-2025) & (US$ Million)
 Table 107. SSI Diagnostica Recent Development
 Table 108. GD Animal Health Company Details
 Table 109. GD Animal Health Business Overview
 Table 110. GD Animal Health Antiserum Product
 Table 111. GD Animal Health Revenue in Antiserum Business (2020-2025) & (US$ Million)
 Table 112. GD Animal Health Recent Development
 Table 113. MicroPharm Company Details
 Table 114. MicroPharm Business Overview
 Table 115. MicroPharm Antiserum Product
 Table 116. MicroPharm Revenue in Antiserum Business (2020-2025) & (US$ Million)
 Table 117. MicroPharm Recent Development
 Table 118. Peptide Institute Inc. Company Details
 Table 119. Peptide Institute Inc. Business Overview
 Table 120. Peptide Institute Inc. Antiserum Product
 Table 121. Peptide Institute Inc. Revenue in Antiserum Business (2020-2025) & (US$ Million)
 Table 122. Peptide Institute Inc. Recent Development
 Table 123. Rare Disease Therapeutics Company Details
 Table 124. Rare Disease Therapeutics Business Overview
 Table 125. Rare Disease Therapeutics Antiserum Product
 Table 126. Rare Disease Therapeutics Revenue in Antiserum Business (2020-2025) & (US$ Million)
 Table 127. Rare Disease Therapeutics Recent Development
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Antiserum Picture
 Figure 2. Global Antiserum Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antiserum Market Share by Type: 2024 VS 2031
 Figure 4. Antitoxin Serum Features
 Figure 5. Antibacterial Serum Features
 Figure 6. Antiviral Serum Features
 Figure 7. Others Features
 Figure 8. Global Antiserum Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Antiserum Market Share by Application: 2024 VS 2031
 Figure 10. Clinical Case Studies
 Figure 11. Laboratory Case Studies
 Figure 12. Antiserum Report Years Considered
 Figure 13. Global Antiserum Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Antiserum Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Antiserum Market Share by Region: 2024 VS 2031
 Figure 16. Global Antiserum Market Share by Players in 2024
 Figure 17. Global Top Antiserum Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiserum as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Antiserum Revenue in 2024
 Figure 19. North America Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Antiserum Market Share by Country (2020-2031)
 Figure 21. United States Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Antiserum Market Share by Country (2020-2031)
 Figure 25. Germany Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Antiserum Market Share by Region (2020-2031)
 Figure 33. China Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Antiserum Market Share by Country (2020-2031)
 Figure 41. Mexico Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Antiserum Market Share by Country (2020-2031)
 Figure 45. Turkey Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. BD Revenue Growth Rate in Antiserum Business (2020-2025)
 Figure 49. Bio-Rad Revenue Growth Rate in Antiserum Business (2020-2025)
 Figure 50. Shanghai Serum Bio-Technology Co., Ltd. Revenue Growth Rate in Antiserum Business (2020-2025)
 Figure 51. China National Pharmaceutical Group Revenue Growth Rate in Antiserum Business (2020-2025)
 Figure 52. CSL Revenue Growth Rate in Antiserum Business (2020-2025)
 Figure 53. Merck Revenue Growth Rate in Antiserum Business (2020-2025)
 Figure 54. BTG Revenue Growth Rate in Antiserum Business (2020-2025)
 Figure 55. Pfizer Revenue Growth Rate in Antiserum Business (2020-2025)
 Figure 56. Haffkine Bio-Pharmaceutical Revenue Growth Rate in Antiserum Business (2020-2025)
 Figure 57. Vins Bioproducts Revenue Growth Rate in Antiserum Business (2020-2025)
 Figure 58. Bharat Serums and Vaccines Revenue Growth Rate in Antiserum Business (2020-2025)
 Figure 59. SSI Diagnostica Revenue Growth Rate in Antiserum Business (2020-2025)
 Figure 60. GD Animal Health Revenue Growth Rate in Antiserum Business (2020-2025)
 Figure 61. MicroPharm Revenue Growth Rate in Antiserum Business (2020-2025)
 Figure 62. Peptide Institute Inc. Revenue Growth Rate in Antiserum Business (2020-2025)
 Figure 63. Rare Disease Therapeutics Revenue Growth Rate in Antiserum Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Serum Market Research Report 2025
Global His Tag Antibody Market Research Report 2024
Global BAG1 Antibody Market Research Report 2024
Global Research Grade Antibodies Market Research Report 2024
Global Bcl 2 Antibody Market Research Report 2024
Global DCAF13 Antibody Market Research Report 2024
Global Avian Antisera Market Research Report 2025
Global Rabies Antiserum Market Research Report 2024
Global Venom Antiserum Market Insights Forecast to 2030
Global Antivenom Serum Market Research Report 2024
Global Snake Venom Antiserum Market Insights Forecast to 2030
Global Antivenom Market Insights Forecast to 2030
Global H2AC8 Antibody Market Research Report 2024
Global Anti Venom Market Insights Forecast to 2030
Global BAGE2 Antibody Market Research Report 2024
B7 H3 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Animal Serum Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
E2 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global F11R Antibody Market Research Report 2024
Global Antitoxin Serum Market Research Report 2024

RELATED REPORTS

Global Nano Porous Silicon–carbon Anode Material Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0F17509
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Foam Board Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16F19834
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Copper Wires Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5U6954
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Quartz Fiber Cloth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20G17359
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions